EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 12th, 2010 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Washington
THIS EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into as of the 12th day of October 2009, by and between SEATTLE GENETICS, INC., a Delaware corporation (“Company”) and Bruce J. Seeley (“Executive”).
COLLABORATION AGREEMENTCollaboration Agreement • March 12th, 2010 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
This COLLABORATION AGREEMENT (the “Agreement”) is entered into on December 14, 2009 (the “Effective Date”) by and between Seattle Genetics, Inc., a Delaware corporation, with its principal place of business at 21823 30th Drive SE, Bothell, WA 98021 (“SGI”), and Millennium Pharmaceuticals, Inc., with its principal place of business at 40 Landsdowne Street, Cambridge, MA 02139 (“MPI”). SGI and MPI are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDMENT TO COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 12th, 2010 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • California
This Amendment to the Collaboration and License Agreement (the “Amendment”), effective as of November 20, 2009 (the “Amendment Effective Date”), is made by and between Seattle Genetics, Inc., a Delaware corporation having offices at 21823 30th Drive S.E., Bothell, WA 98021 (“SGI”), and Agensys, Inc., a California corporation and a wholly-owned subsidiary of Astellas Pharma Inc., having offices at 1545 17th Street, Santa Monica, CA 90404 (“Agensys”).
